Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 1 of the 13 calendar months from Oct 2025 to Oct 2026: Aug 2026.
- Largest single sale: $11.0M (187,044 shares) of Moderna on Aug 5, 2026. Filing
- Last sale before this period: Feb 16, 2024.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Moderna (MRNA) | Chief Executive Officer, Director | Dec 7, 2018 | Aug 7, 2026 |
| Generate Biomedicines, Inc. (GENB) | Director | Feb 26, 2026 | Mar 2, 2026 |
Also a director at
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 6, 2026, Moderna: 252,469 shares acquired by exercising options. 1 filing: 1
- Aug 5, 2026, Moderna: sold 499,246 shares for $28.7M, under a disclosed plan; 499,246 shares acquired by exercising options. 1 filing: 1
- Mar 2, 2026, Generate Biomedicines, Inc.: 724,160 shares converted (some held indirectly). 1 filing: 1
- Feb 11, 2026, Moderna: 11,271 shares awarded; 5,450 shares withheld by the company for taxes. 1 filing: 1
- Dec 11, 2025, Moderna: 688,073 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.